E. Ohman J:or Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

E. Ohman J:or Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$667K	Hold	19,680	–	–	0.02%	367
2026 Q1	$593K	Hold	19,680	–	–	0.02%	365
2025 Q4	$614K	Buy	+19,680	New	+$485K	0.01%	397
2017 Q4	–	Sell	-206,483	Closed	-$3.63M	–	572
2017 Q3	$3.63M	Buy	+206,483	New	+$4.65M	0.32%	64

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

TAM

Todd Asset Management Louisville, Kentucky $5.63B AUM 45.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

KHLMVGHM

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $2.44B AUM 24.95% 1-Year Est. Return

E. Ohman J:or Asset Management's TEVA Position: Q2 2026 in Review

E. Ohman J:or Asset Management held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 19,680 shares worth $667K. The position accounts for 0.02% of the portfolio, ranked #367.

E. Ohman J:or Asset Management first reported a position in TEVA in Q3 2017 and has held it in 4 quarters since. The position peaked at $3.63M in Q3 2017. 363 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

E. Ohman J:or Asset Management held 19,680 shares of Teva Pharmaceuticals worth $667K as of Q2 2026.
E. Ohman J:or Asset Management left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up 0.02% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #367 holding.
E. Ohman J:or Asset Management first reported a position in Teva Pharmaceuticals in Q3 2017 and has held it in 4 quarters since.
E. Ohman J:or Asset Management's Teva Pharmaceuticals position peaked at $3.63M in Q3 2017.
363 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.